First Trust Advisors
LUMO

First Trust Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

First Trust Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,178
Closed -$210K – 2468
2017
Q2 		$210K Buy
3,178
+318
+11% +$39.4K ﹤0.01% 2276
2017
Q1 		$620K Buy
+2,860
New +$409K ﹤0.01% 2000

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

First Trust Advisors's LUMO Position: Q3 2017 in Review

First Trust Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 3,178 shares — an estimated $210K sold.

First Trust Advisors first reported a position in LUMO in Q1 2017 and held it in 2 quarters. The position peaked at $620K in Q1 2017. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • First Trust Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • First Trust Advisors sold 3,178 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $210K.
  • First Trust Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • First Trust Advisors's Lumos Pharma, Inc. Common Stock position peaked at $620K in Q1 2017.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on First Trust Advisors's 13F filing for Q3 2017, filed 24 Oct 2017.